dronabinol has been researched along with Addiction, Opioid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Bramness, JG; Hjellvik, V; Skurtveit, S; Stubhaug, A | 1 |
| Böhm, R; Gastmeier, A; Gastmeier, K; Herdegen, T; Rottmann, F | 1 |
| Little, MA; Morris, JD; Pebley, K | 1 |
| Compton, P; De Aquino, JP; Meyerovich, J; Pittman, B; Ranganathan, M; Rogan, M; Sofuoglu, M; Xie, CZ | 1 |
| Le Foll, B | 1 |
| Balter, R; Bedi, G; Comer, SD; Cooper, ZD; Haney, M; Ramesh, D | 1 |
| Bonnet, U; Isbruch, K; Stratmann, U | 1 |
| Bisaga, A; Carpenter, KM; Glass, A; Haney, M; Levin, FR; Mariani, JJ; Mishlen, K; Nunes, EV; Pavlicova, M; Raby, WN; Sullivan, MA | 1 |
| Babalonis, S; Elayi, SC; Jicha, CJ; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Ball, SA; D'Souza, DC; Radhakrishnan, R; Wilkinson, ST; Yarnell, S | 1 |
| Cherry, C; Eaton, L; Grebler, T; Kalichman, MO; Kalichman, SC; Kegler, C; Washington, C | 1 |
| France, CP; Gerak, LR | 1 |
| Babalonis, S; Elayi, SC; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Daugé, V; Giros, B; Morel, LJ | 1 |
| Brunet, B; Goullé, JP; Mura, P; Saussereau, E | 1 |
| Eisch, AJ; Mandyam, CD | 1 |
| Epstein, DH; Ghitza, UE; Preston, KL | 1 |
| Boren, JJ; Henningfield, JE; Jasinski, DR; Johnson, RE; Lange, WR; Lukas, SE | 1 |
| Henningfield, JE; Hickey, JE; Jasinski, DR; Johnson, RE | 1 |
| Nightingale, SL | 1 |
| Kranzler, HR; McLaughlin, L; Stone, J | 1 |
| Kauert, G; Röhrich, J | 1 |
| Aubert, JF; Beslot, F; Böhme, GA; Cossu, G; Fratta, W; Imperato, A; Ledent, C; Parmentier, M; Pedrazzini, T; Petitet, F; Roques, BP; Valverde, O; Vassart, G | 1 |
3 review(s) available for dronabinol and Addiction, Opioid
| Article | Year |
|---|---|
Opioid-sparing effects of cannabinoids: Myth or reality?
Topics: Analgesics, Opioid; Animals; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Evaluation, Preclinical; Drug Synergism; Humans; Morphine; Opioid-Related Disorders; Pain | 2021 |
Marijuana Legalization: Impact on Physicians and Public Health.
Topics: Automobile Driving; Cannabis; Cognition Disorders; Dronabinol; Humans; Illicit Drugs; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Opioid-Related Disorders; Prevalence; Psychotic Disorders; Public Health; United States | 2016 |
[Workplace testing of drugs of abuse and psychotropic drugs].
Topics: Amphetamine-Related Disorders; Cannabinoids; Chronic Disease; Cocaine-Related Disorders; Dronabinol; False Negative Reactions; False Positive Reactions; France; Humans; Illicit Drugs; Opioid-Related Disorders; Psychotropic Drugs; Reproducibility of Results; Saliva; Substance Abuse Detection; Substance-Related Disorders; Workplace | 2012 |
6 trial(s) available for dronabinol and Addiction, Opioid
| Article | Year |
|---|---|
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
Topics: Analgesics, Opioid; Dronabinol; Female; Humans; Male; Methadone; Opioid-Related Disorders; Pain | 2023 |
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Topics: Adult; Analgesia; Analgesics, Opioid; Double-Blind Method; Dronabinol; Drug Synergism; Female; Humans; Male; Marijuana Smoking; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain Measurement; Young Adult | 2018 |
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
Topics: Adult; Cannabinoids; Delayed-Action Preparations; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance; Substance Withdrawal Syndrome; Young Adult | 2015 |
Safety of oral dronabinol during opioid withdrawal in humans.
Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Blood Pressure; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pupil; Substance Withdrawal Syndrome; Tachycardia, Sinus; Treatment Outcome; Young Adult | 2015 |
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Young Adult | 2016 |
Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Behavior Therapy; Black or African American; Cocaine; Cocaine-Related Disorders; Dronabinol; Female; Humans; Male; Marijuana Abuse; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Sex Distribution; Substance Abuse Detection; Time Factors; Token Economy; Treatment Outcome; White People | 2007 |
14 other study(ies) available for dronabinol and Addiction, Opioid
| Article | Year |
|---|---|
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database.
Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Cannabidiol; Databases, Factual; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Norway; Opioid-Related Disorders; Practice Patterns, Physicians' | 2022 |
[Cannabinoids reduce opioid use in older patients with pain : Retrospective three-year analysis of data from a general practice].
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Cannabinoids; Chronic Pain; Dronabinol; Female; General Practice; Humans; Male; Morphine; Opioid-Related Disorders; Quality of Life; Retrospective Studies | 2023 |
Vaping Opioids: Should We Be Worried?
Topics: Adolescent; Analgesics, Opioid; Dronabinol; Electronic Nicotine Delivery Systems; Humans; Opioid-Related Disorders; Vaping; Young Adult | 2023 |
[No opiates against cannabis hyperemesis syndrome].
Topics: Adult; Antiemetics; Dronabinol; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Germany; Humans; Infusions, Intravenous; Male; Marijuana Abuse; Methadone; Morphine; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Vomiting | 2014 |
Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cocaine; Cocaine-Related Disorders; Coinfection; Cross-Sectional Studies; Dronabinol; Female; Georgia; Health Behavior; Hepatitis Antibodies; Hepatitis C, Chronic; HIV Infections; Humans; Male; Marijuana Abuse; Medication Adherence; Middle Aged; Opioid-Related Disorders; Prevalence; Substance Abuse Detection; Substance-Related Disorders; Viral Load | 2015 |
Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Opioid; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Heart Rate; Macaca mulatta; Morphine; Morpholines; Naphthalenes; Opioid-Related Disorders; Pain Measurement; Substance Withdrawal Syndrome | 2016 |
Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Topics: Aging; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Conditioning, Classical; Dronabinol; Enkephalins; Male; Maternal Deprivation; Morphine; Opioid-Related Disorders; Protein Precursors; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; RNA, Messenger; Self Administration; Space Perception; Time Factors | 2009 |
Drug dependence and addiction, II: Adult neurogenesis and drug abuse.
Topics: Age Factors; Alcoholism; Animals; Cell Count; Cell Cycle; Cell Division; Dentate Gyrus; Dronabinol; Ethanol; Hippocampus; Histones; Illicit Drugs; Marijuana Abuse; Mice; Narcotics; Neuronal Plasticity; Neurons; Opioid-Related Disorders; Proliferating Cell Nuclear Antigen | 2004 |
Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.
Topics: Anti-Anxiety Agents; Buprenorphine; Double-Blind Method; Dronabinol; Drug Synergism; Heroin Dependence; Humans; Marijuana Abuse; Methadone; Opioid-Related Disorders; Pentazocine; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tripelennamine | 1984 |
Progress report of the NIDA Addiction Research Center, Baltimore, Maryland, 1982.
Topics: Animals; Behavior, Animal; Buprenorphine; Chlordiazepoxide; Dronabinol; Humans; Nicotine; Opioid-Related Disorders; Pentobarbital; Smoking; Substance-Related Disorders | 1983 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anorexia; Dronabinol; Humans; Methadone; Mollusca; Opioid-Related Disorders; Shellfish; United States; United States Food and Drug Administration; Vibrio Infections; Weight Loss | 1993 |
Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable.
Topics: Cocaine; Dronabinol; Humans; Marijuana Abuse; Narcotics; Nursing Assessment; Opioid-Related Disorders; Patient Care Team; Point-of-Care Systems; Reagent Kits, Diagnostic; Sensitivity and Specificity; Substance Abuse Detection; Substance-Related Disorders | 1995 |
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dronabinol; Expert Testimony; Gas Chromatography-Mass Spectrometry; Hair; Heroin Dependence; Humans; Illicit Drugs; Marijuana Abuse; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Psychotropic Drugs; Sensitivity and Specificity | 1996 |
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Blood Pressure; Body Temperature; Cannabinoids; Dronabinol; Heart Rate; Mice; Mice, Knockout; Morphine; Motor Activity; Narcotics; Opioid-Related Disorders; Pain Threshold; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, kappa; Reinforcement, Psychology; Substance Withdrawal Syndrome | 1999 |